908 Devices to Participate in the Canaccord Genuity 46th Annual Growth Conference
Get Alerts MASS Hot Sheet
Join SI Premium – FREE
BURLINGTON, Mass.--(BUSINESS WIRE)-- 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will participate in the upcoming Canaccord Genuity 46th Annual Growth Conference.
908 Devices’ management is scheduled to present on Wednesday, August 12 at 12:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.908devices.com.
About 908 Devices
908 Devices is revolutionizing chemical analysis with its simple handheld devices, addressing life-altering applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers in vital health, safety and defense tech applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure, and global security threats. The Company designs and manufactures innovative products that bring together the power of complementary analytical technologies, software automation, and machine learning. For more information, visit www.908devices.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260729984797/en/
IR & Media
Barbara Russo
[email protected]
Source: 908 Devices Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Globality Launches Glo 2.0, the First Fully Autonomous Sourcing Platform
- Apex Expands Trinity Zone with Step-out Hole Returning 197.5 m Interval of 2.12% REO at the Rift Rare Earth Project in SE Nebraska
- Logitech Unveils MX Keypad for Developers: The Customizable Multi-App AI Control Center
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share